30 phenotypes from 3 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Clec16acurt/Clec16acurt SWR/J-Clec16acurt/GrsrJ	abnormal digit morphology	J:172931
	decreased body size	J:172931
	decreased body weight	J:172931
	impaired hearing	J:172931
	increased or absent threshold for auditory brainstem response	J:172931
	narrow eye opening	J:172931
	perinatal lethality, incomplete penetrance	J:172931
	premature death	J:172931
	preweaning lethality, incomplete penetrance	J:172931
	Purkinje cell degeneration	J:251104
	wavy tail	J:172931
Clec16aem1(IMPC)J/Clec16a+ C57BL/6NJ-Clec16aem1(IMPC)J/Mmjax	increased exploration in new environment	J:211773
Clec16aem1(IMPC)J/Clec16aem1(IMPC)J C57BL/6NJ-Clec16aem1(IMPC)J/Mmjax	abnormal body wall morphology	J:211773
	abnormal embryo size	J:211773
	preweaning lethality, complete penetrance	J:211773
Clec16atm1.1Hhak/Clec16atm1.1Hhak involves: C57BL/6 * SJL	no abnormal phenotype detected	J:214528
Clec16atm1.1Hhak/Clec16atm1.1Hhak Ndor1Tg(UBC-cre/ERT2)1Ejb/0 involves: 129S/SvEv * C57BL/6 * SJL	abnormal mitophagy	J:214528
	decreased oxygen consumption	J:214528
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0 involves: C57BL/6 * C57BL/6J * CBA/J * SJL	abnormal endoplasmic reticulum morphology	J:214528
	abnormal mitochondrial morphology	J:214528
	abnormal mitophagy	J:214528
	abnormal pancreatic alpha cell morphology	J:214528
	abnormal pancreatic beta cell morphology	J:214528
	abnormal pancreatic beta cell physiology	J:214528
	decreased insulin secretion	J:214528
	decreased oxygen consumption	J:214528
	disorganized mitochondrial cristae	J:214528
	normal endocrine/exocrine gland phenotype	J:214528
	hyperglycemia	J:214528
	impaired glucose tolerance	J:214528
	increased mitochondrial size	J:214528
Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr/0 NOD-Tg(CMV-GFP,-RNAi:Clec16a)KD3Kslr	increased physiological sensitivity to xenobiotic	J:285312